{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:09:23Z","timestamp":1771625363412,"version":"3.50.1"},"reference-count":16,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,7]]},"abstract":"<jats:p>In Denmark, both influenza A(H1N1)pdm09 and influenza B co-circulated in the 2015\/16 season. We estimated the vaccine effectiveness (VE) of the trivalent influenza vaccine in patients\u200965 years and older using the test-negative case\u2013control design. The adjusted VE against influenza A(H1N1)pdm09 was 35.0% (95% confidence interval (CI): 11.1\u201352.4) and against influenza B 4.1% (95% CI: \u221222.0 to 24.7). The majority of influenza A(H1N1)pdm09 circulating in 2015\/16 belonged to the new genetic subgroup subclade 6B.1.<\/jats:p>","DOI":"10.2807\/1560-7917.es.2016.21.14.30189","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T11:01:51Z","timestamp":1461322911000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":25,"title":["Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015\/16 \u2013 a rapid epidemiological and virological assessment"],"prefix":"10.2807","volume":"21","author":[{"given":"Hanne Dorthe","family":"Emborg","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyra Grove","family":"Krause","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Herlev Hospital, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Kragh","family":"Thomsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Bohn","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Nielsine","family":"Skov","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Odense University Hospital, Odense C, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui Chen","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenette Sandborg","family":"Weinreich","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thea K\u00f8lsen","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Microbiological Diagnostics and Virology, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"R\u00f8nn","sequence":"additional","affiliation":[{"name":"Department of Microbiological Diagnostics and Virology, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Trebbien","sequence":"additional","affiliation":[{"name":"Department of Microbiological Diagnostics and Virology, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7995","reference":[{"key":"r1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Seasonal influenza 2015-2016 in the EU\/EEA countries. Risk assessment. Stockholm: ECDC; 2016. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/seasonal-influenza-risk-assessment-2015-2016.pdf"},{"issue":"1","key":"r2","doi-asserted-by":"crossref","first-page":"20667","DOI":"10.2807\/1560-7917.ES2014.19.1.20667","article-title":"The Danish Microbiology Database (MiBa) 2010 to 2013.","volume":"19","author":"Voldstedlund","year":"2014","journal-title":"Euro Surveill"},{"issue":"17","key":"r3","doi-asserted-by":"crossref","first-page":"20155","DOI":"10.2807\/ese.17.17.20155-en","article-title":"The Danish vaccination register.","volume":"17","author":"Grove Krause","year":"2012","journal-title":"Euro Surveill"},{"issue":"3","key":"r4","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences.","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"issue":"12","key":"r5","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"r6","unstructured":"FluSurver. Influenza surveillance - prepared for next wave. Singapore; A*STAR Bioinformatics Institute. [Accessed: 14 Mar 2016]. Available from: http:\/\/flusurver.bii.a-star.edu.sg\/"},{"key":"r7","unstructured":"World Health Organization (WHO) Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: WHO; 2011. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44518\/1\/9789241548090_eng.pdf"},{"issue":"50","key":"r8","doi-asserted-by":"crossref","first-page":"20995","DOI":"10.2807\/1560-7917.ES2014.19.50.20995","article-title":"ESwab challenges influenza virus propagation in cell cultures.","volume":"19","author":"Trebbien","year":"2014","journal-title":"Euro Surveill"},{"issue":"6","key":"r9","doi-asserted-by":"crossref","first-page":"30134","DOI":"10.2807\/1560-7917.ES.2016.21.6.30134","article-title":"Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study.","volume":"21","author":"Kissling","year":"2016","journal-title":"Euro Surveill"},{"issue":"13","key":"r10","doi-asserted-by":"crossref","first-page":"30179","DOI":"10.2807\/1560-7917.ES.2016.21.13.30179","article-title":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 mid-season results.","volume":"21","author":"Pebody","year":"2016","journal-title":"Euro Surveill"},{"key":"r11","unstructured":"Chiu SS, Feng S, Chan KH, Lo JY, Chan EL, So LY, et al. Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. Vaccine. 2016;pii: S0264-410X(16)30005-6"},{"issue":"3","key":"r12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"r13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/infdis\/jiu048","article-title":"Influenza A\/subtype and B\/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.","volume":"210","author":"Skowronski","year":"2014","journal-title":"J Infect Dis"},{"key":"r14","unstructured":"European Centre for Disease Prevention and Control (ECDC). Influenza situation in week 9 2016. Stockholm: ECDC; 2016. Available from: http:\/\/ecdc.europa.eu\/en\/healthtopics\/seasonal_influenza\/epidemiological_data\/Pages\/Latest_surveillance_data.aspx"},{"issue":"7","key":"r15","doi-asserted-by":"crossref","first-page":"30139","DOI":"10.2807\/1560-7917.ES.2016.21.7.30139","article-title":"Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014\/15.","volume":"21","author":"Valenciano","year":"2016","journal-title":"Euro Surveill"},{"issue":"8","key":"r16","first-page":"30147","article-title":"WHO recommendations on the composition of the 2016\/17 influenza virus vaccines in the northern hemisphere.","volume":"21","year":"2016","journal-title":"Euro Surveill"}],"container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:08:02Z","timestamp":1663240082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2016.21.14.30189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,7]]},"references-count":16,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4,7]]}},"URL":"https:\/\/doi.org\/10.2807\/1560-7917.es.2016.21.14.30189","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,7]]}}}